LAACClamp Inc.
StreetZero Signal 71
About LAACClamp Inc.
LAACClamp Inc. develops LAACClamp, a curved implantable clip for surgical left atrial appendage exclusion. The company was established as a Delaware C-corporation in November 2023 to commercialize cardiac surgery innovations created by founder Nahush A. Mokadam, MD. It holds an exclusive worldwide license to related intellectual property and is headquartered in Columbus, OH.
LATEST FUNDINGPrivate Placement
$900K
Announced 2026-10-05
TOTAL RAISED$900,000
IN THE NEWS
- 🔗 LAACClamp Inc™ – LAACClamp™ is a curved implantable clip for surgical left atrial appendage exclusion.
- 🔗 Biotech funding in 2025: The Labiotech tracker
- 🔗 Biotech Funding 2025 Tracker: Follow the Latest Raises, Rounds and R&D Momentum
- 🔗 The Week’s 10 Biggest Funding Rounds: Another Big Week For Biotech As Tome Raises $213M
- 🔗 Puma Biotechnology Funding: How Much Did They Raise & Key Investors
EMPLOYEES—
FOUNDED2023
HQColumbus, OH, United States
Industry
Biotechnology
Tags
BiotechnologyMedical DeviceCardiac Surgery
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- LAACClamp develops a curved implantable clip for left atrial appendage exclusion.
- Founded in November 2023 as a Delaware C-corporation by Nahush A. Mokadam, MD.
- Raised $900,000 via private placement with location in Columbus, OH.
- Holds exclusive license to commercialize cardiac surgery innovations.
Ask StreetZero about LAACClamp Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account